BOLD (STOCKS)

    Boundless Bio, Inc. Common Stock

    $1.110000
    -0.010000 (-0.89%)
    Prev close: $1.120000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Zachary D. Hornby
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $24.85M
    Employees
    64
    P/E (TTM)
    -0.40
    P/B (TTM)
    0.23
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2019)
    Revenues $0.00
    Operating Expenses $184.33M
    Depreciation and Amortization $7.38M
    Research and Development $142.99M
    Other Operating Expenses $33.97M
    Operating Income/Loss -$184.33M
    Income/Loss From Continuing Operations After Tax -$175.49M
    Income/Loss From Continuing Operations Before Tax -$175.49M
    Net Income/Loss -$175.49M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$175.49M
    Net Income/Loss Available To Common Stockholders, Basic -$175.49M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Assets $441.51M
    Current Assets $356.38M
    Noncurrent Assets $85.13M
    Fixed Assets $38.17M
    Intangible Assets $8.00M
    Other Non-current Assets $38.96M
    Liabilities $58.05M
    Current Liabilities $27.85M
    Accounts Payable $9.91M
    Wages $8.31M
    Other Current Liabilities $9.64M
    Noncurrent Liabilities $30.20M
    Equity $383.46M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $383.46M
    Liabilities And Equity $441.51M
    Net Cash Flow From Operating Activities -$147.40M
    Net Cash Flow From Operating Activities, Continuing -$147.40M
    Net Cash Flow From Investing Activities -$119.67M
    Net Cash Flow From Investing Activities, Continuing -$119.67M
    Net Cash Flow From Financing Activities $226.47M
    Net Cash Flow From Financing Activities, Continuing $226.47M
    Net Cash Flow -$40.61M
    Net Cash Flow, Continuing -$40.61M
    Comprehensive Income/Loss -$175.20M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$175.20M
    Other Comprehensive Income/Loss $286.00K